|
3rd quarter |
|
January - September | ||||||
|
2011 |
2012 |
in € millions |
2011 |
2012 | ||||
|
|
|
|
|
| ||||
|
Continuing operations | ||||||||
|
4,051 |
4,280 |
Revenue |
11,910 |
12,658 | ||||
|
(2,511) |
(2,624) |
Cost of sales |
(7,247) |
(7,764) | ||||
|
1,540 |
1,656 |
Gross profit |
4,663 |
4,894 | ||||
|
– |
(2,478) |
Impairment |
– |
(2,478) | ||||
|
(857) |
(943) |
Selling expenses |
(2,539) |
(2,735) | ||||
|
(293) |
(336) |
General and administrative expenses |
(887) |
(1,011) | ||||
|
(87) |
(100) |
Research and development expenses |
(258) |
(293) | ||||
|
(2) |
(32) |
Other operating income/(expenses) |
27 |
(44) | ||||
|
301 |
(2,233) |
Operating income/(loss) |
1,006 |
(1,667) | ||||
|
(70) |
(66) |
Net financing expenses |
(197) |
(213) | ||||
|
9 |
5 |
Results from associates and joint ventures |
24 |
14 | ||||
|
240 |
(2,294) |
Profit/(loss) before tax |
833 |
(1,866) | ||||
|
(74) |
(56) |
Income tax |
(246) |
(182) | ||||
|
166 |
(2,350) |
Profit/(loss) for the period from continuing operations |
587 |
(2,048) | ||||
|
|
|
|
|
| ||||
|
Discontinued operations | ||||||||
|
1 |
(22) |
Profit/(loss) for the period from discontinued operations |
14 |
(17) | ||||
|
167 |
(2,372) |
Profit/(loss) for the period |
601 |
(2,065) | ||||
|
|
|
|
|
| ||||
|
Attributable to | ||||||||
|
149 |
(2,382) |
Shareholders of the company |
545 |
(2,110) | ||||
|
18 |
10 |
Non-controlling interests |
56 |
45 | ||||
|
167 |
(2,372) |
Profit/(loss) for the period |
601 |
(2,065) | ||||
Tools:
